Application of diabetes vaccine based on (M)T-DC technology
A diabetes vaccine, T-DC technology, applied in the field of vaccines, can solve problems such as cardiovascular and cerebrovascular damage, vascular cell function decline, blood supply system function decline, etc., to achieve the effect of strengthening, restoring pancreatic function, and preventing relapse or reinfection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0017] The present invention will be described in detail below in combination with specific embodiments.
[0018] Targeted dendritic cell therapy (Target-Dendritic Cell, T-DC) is to collect autologous peripheral blood mononuclear cells, and add other cytokines in the laboratory to obtain transformed dendritic cells (dendritic cells) with strong antigen-presenting function. , DC). The day before the reinfusion, a specially synthesized single-epitope polyantigen peptide is added, and the DC recognizes and captures the single-epitope polyantigen peptide to obtain mature dendritic cells that are sensitized to the patient's infectious agent virus. Migration and immune activity, go deep into the deep part of the lesion and the surrounding diseased tissue, induce the body to produce a large number of cytotoxic T lymphocytes that have a killing effect on specific antigens, thereby specifically clearing the free virus and intracellular virus in the deep layer of infection and around it...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com